These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 28345395
1. Evaluation of the Predictive Value of CHA2DS2-VASc Score for In-Stent Restenosis. Yilmaz S, Akboga MK, Aras D, Topaloglu S. Angiology; 2018 Jan; 69(1):38-42. PubMed ID: 28345395 [Abstract] [Full Text] [Related]
2. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents. Kurtul A. Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046 [Abstract] [Full Text] [Related]
9. CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study. Kim TH, Yang PS, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, Lip GYH. Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320 [Abstract] [Full Text] [Related]
10. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A. Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [Abstract] [Full Text] [Related]
12. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ. Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [Abstract] [Full Text] [Related]
13. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY. J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744 [Abstract] [Full Text] [Related]
19. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation. Akboğa MK, Yılmaz S, Yalçın R. Anatol J Cardiol; 2021 Nov 10; 25(11):789-795. PubMed ID: 34734812 [Abstract] [Full Text] [Related]
20. Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification. Sambola A, Mutuberría M, García Del Blanco B, Alonso A, Barrabés JA, Alfonso F, Bueno H, Cequier A, Zueco J, Rodríguez-Leor O, Bosch E, Tornos P, García-Dorado D. Circ J; 2016 Nov 10; 80(2):354-62. PubMed ID: 26725763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]